2 TOWER PLACE, SOUTH SAN FRANCISCO, CA
Announces Agreement to Sell Microfluidics Business to ARCHIMED
Provides Update on Sale of Mass Cytometry Business
Reports Second Quarter 2026 Financial Results
Amended material disclosure
Exhibit 99.1
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Stockholders Approve 2026 Equity Incentive Plan and ESPP Amendment
June 2026 Announcement
Q2
Q1
FY 2025
Q3
Notice of Late Filing for Quarterly Report
FY 2024
S-4/A
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Contested Proxy Solicitation Materials
PRER14A
Preliminary Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Specialized Disclosure Report
Correspondence
Submission Upload